News tagged with plos biology
New tumour-killer shows great promise in suppressing cancers
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Cancer
May 21, 2013 |
5 / 5 (3) |
0
Study identifies genes, pathways altered during relaxation response practice
A new study from investigators at the Benson-Henry Institute for Mind/Body Medicine at Massachusetts General Hospital (MGH) and Beth Israel Deaconess Medical Center (BIDMC) finds that elicitation of the relaxation response ...
Psychology & Psychiatry
May 01, 2013 |
5 / 5 (1) |
0
|
Researchers seek to treat protein-based diseases
Scientists at the University of Essex have made a further step towards the potential future development of medicines to help combat a range of diseases currently considered "undruggable".
Diseases, Conditions, Syndromes
Apr 30, 2013 |
not rated yet |
0
Bacteria may contribute to premature births, STDs
(Medical Xpress)—New research at Washington University School of Medicine in St. Louis points to a common species of bacteria as an important contributor to bacterial vaginosis, a condition linked to preterm ...
Medical research
Apr 23, 2013 |
5 / 5 (2) |
0
|
Molecular signaling in early placenta formation gives clues to causes of pregnancy complications
Understanding the molecular control of placenta formation, the organ which enables fetal growth, is critical in diagnosing and treating related pregnancy complications. A group of scientists at the Chinese Academy of Sciences, ...
Medical research
Apr 16, 2013 |
not rated yet |
0
|
Manipulating calcium accumulation in blood vessels may provide a new way to treat heart disease
Hardening of the arteries, or atherosclerosis, is the primary cause of heart disease. It is caused by calcium accumulation in the blood vessels, which leads to arteries becoming narrow and stiff, obstructing blood flow and ...
Cardiology
Apr 09, 2013 |
5 / 5 (1) |
1
Two-drug combo more effective in treating sarcomas, study shows
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have found that when given together, a two-drug combination acts synergistically in test animals modeled with sarcoma tumors. They report ...
Cancer
Apr 09, 2013 |
5 / 5 (1) |
0
|
New foot-and-mouth vaccine signals huge advance in global disease control
(Medical Xpress)—A new vaccine against foot-and-mouth disease that is safer to produce and easier to store has been developed by scientists from the University of Oxford and The Pirbright Institute.
Diseases, Conditions, Syndromes
Mar 28, 2013 |
5 / 5 (3) |
0
|
Study casts light on deadly immune response
(Medical Xpress)—Examining a case study of near-death experiences for six healthy men who volunteered to test an experimental drug in London has yielded important insights into potentially deadly over-reactions ...
Immunology
Mar 19, 2013 |
3 / 5 (2) |
1
|
Scientists discover new mechanisms for relaxing airways using bitter tasting substances
That kale and bitter melon you are eating may someday save your life. An interdisciplinary team of scientists at the University of Massachusetts Medical School have taken a step forward in understanding how the substances ...
Medical research
Mar 05, 2013 |
5 / 5 (1) |
0
|
'Defective' virus surprisingly plays major role in spread of disease
(Medical Xpress)—Defective viruses, thought for decades to be essentially garbage unrelated to the transmission of normal viruses, now appear able to play an important role in the spread of disease, new ...
Diseases, Conditions, Syndromes
Feb 28, 2013 |
5 / 5 (6) |
0
|
Researchers find multiple tests needed to detect infection in low birth-weight newborns
New research by Case Western Reserve University School of Dental Medicine and Yale University School of Medicine finds that cultures commonly used to detect bacterial infections in low birth-weight newborns with early onset ...
Pediatrics
Feb 20, 2013 |
not rated yet |
0
Combo of Avastin, second drug shows promise fighting brain cancer, study finds
The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain ...
Cancer
Feb 14, 2013 |
not rated yet |
0
Study in mice yields Angelman advance
In a new study in mice, a scientific collaboration centered at Brown University lays out in unprecedented detail a neurological signaling breakdown in Angelman syndrome, a disorder that affects thousands ...
Medical research
Feb 13, 2013 |
5 / 5 (2) |
0
|
Gene variants found to affect human lifespan
By broadly comparing the DNA of children to that of elderly people, gene researchers have identified gene variants that influence lifespan, either by raising disease risk or by providing protection from disease.
Genetics
Feb 04, 2013 |
5 / 5 (1) |
0
|
PLoS Biology
PLoS Biology is an American scientific journal covering the full spectrum of the biological sciences that began operation on October 13, 2003.
It was the first journal of the Public Library of Science (PLoS) a non-profit organization which releases scientific content under open access terms. All content in PLoS Biology is published under the Creative Commons "by-attribution" license, abbreviated CCAL[1]. To fund the journal, the publication's business model requires that, in most cases, authors will pay publication costs.
In addition to research articles, PLoS Biology publishes online e-letters in which the readers provide their comments to the articles.
The impact factor of PLoS Biology for 2007, as calculated by the Institute for Scientific Information (ISI), was 13.5. To put this in context, it is the highest-ranked of all journals in the ISI category 'Biology'.
The current Academic Editor in Chief is Jonathan Eisen from U. C. Davis.
For more information about PLoS Biology, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
